Article info

Original research
Systematic review and meta-analysis of anakinra, sarilumab, siltuximab and tocilizumab for COVID-19
Free

Authors

  1. Correspondence to Dr Fasihul A Khan, Centre for Respiratory Research, University of Nottingham, Nottingham NG7 2RD, UK; fasihul.khan{at}nottingham.ac.uk
View Full Text

Citation

Khan FA, Stewart I, Fabbri L, et al
Systematic review and meta-analysis of anakinra, sarilumab, siltuximab and tocilizumab for COVID-19

Publication history

  • Received May 11, 2020
  • Revised January 10, 2021
  • Accepted January 21, 2021
  • First published February 12, 2021.

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.